Market Tracker

02/27 6:02pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.51
Delayed Data
As of Feb 27
 -0.12 / -1.81%
Today’s Change
3.10
Today|||52-Week Range
7.84
-13.89%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close6.63
Today’s open6.66
Day’s range6.24 - 6.69
Volume1,056,369
Average volume (3 months)917,999
Market cap$452.8M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+115.79%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratio130.2
Price/Sales37.83
Price/Book5.01

Competitors

 Today’s
change
Today’s
% change
NWBONorthwest Biotherape...-0.09-1.21%
DVAXDynavax Technologies...+0.10+0.57%
PRQRProQR Therapeutics N...-0.94-4.75%
SRNESorrento Therapeutic...-0.34-2.56%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts